{"id":"https://openalex.org/W4392684776","doi":"https://doi.org/10.1158/0008-5472.c.6508556","title":"Data from An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma","display_name":"Data from An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4392684776","doi":"https://doi.org/10.1158/0008-5472.c.6508556"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6508556","doi":"https://doi.org/10.1158/0008-5472.c.6508556","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508556","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6508556","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029143392","display_name":"Jessica L.F. Teh","orcid":"https://orcid.org/0000-0003-1841-671X","observed_orcids":["https://orcid.org/0000-0003-1841-671X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica L.F. Teh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085398803","display_name":"Timothy J. Purwin","orcid":"https://orcid.org/0000-0002-7053-8039","observed_orcids":["https://orcid.org/0000-0002-7053-8039"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy J. Purwin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047768044","display_name":"Evan J. Greenawalt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evan J. Greenawalt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022471130","display_name":"Inna Chervoneva","orcid":"https://orcid.org/0000-0002-9104-4505","observed_orcids":["https://orcid.org/0000-0002-9104-4505"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inna Chervoneva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057893861","display_name":"Allison F. Goldberg","orcid":"https://orcid.org/0000-0001-6188-0863","observed_orcids":["https://orcid.org/0000-0001-6188-0863"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allison Goldberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048327749","display_name":"Michael A. Davies","orcid":"https://orcid.org/0000-0002-0977-0912","observed_orcids":["https://orcid.org/0000-0002-0977-0912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Davies","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062746446","display_name":"Andrew E. Aplin","orcid":"https://orcid.org/0000-0002-2734-3244","observed_orcids":["https://orcid.org/0000-0002-2734-3244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew E. Aplin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cutaneous-melanoma","display_name":"cutaneous melanoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8519999980926514},{"id":"https://openalex.org/keywords/melanoma-xenografts","display_name":"melanoma xenografts","score":0.875},{"id":"https://openalex.org/keywords/cell-cycle","display_name":"cell cycle","score":0.40700000524520874},{"id":"https://openalex.org/keywords/retinoblastoma","display_name":"retinoblastoma","score":0.9509999752044678},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8500000238418579},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6269999742507935},{"id":"https://openalex.org/keywords/anti-apoptotic-proteins","display_name":"anti-apoptotic proteins","score":0.8650000095367432}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7184877395629883},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5819516777992249},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5615217089653015},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4520624876022339},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.43355539441108704},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2544228732585907},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22978392243385315},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.10021382570266724}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6508556","doi":"https://doi.org/10.1158/0008-5472.c.6508556","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508556","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6508556","doi":"https://doi.org/10.1158/0008-5472.c.6508556","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6508556","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2502300311","https://openalex.org/W2484218825","https://openalex.org/W2339921159","https://openalex.org/W3164873739","https://openalex.org/W3043231002","https://openalex.org/W2145657367","https://openalex.org/W4413307651","https://openalex.org/W2740898852","https://openalex.org/W2969606677","https://openalex.org/W2774356865"],"abstract_inverted_index":{"Abstract":[0],"Aberrant":[1],"cell-cycle":[2],"progression":[3,18],"is":[4,136],"a":[5,170],"hallmark":[6],"feature":[7],"of":[8,23,53,98,126,149,154,169,178],"cancer":[9],"cells.":[10],"Cyclin-dependent":[11],"kinases":[12],"4":[13],"and":[14,40,67,105,121,129,163,166,182,198],"6":[15],"(CDK4/6)":[16],"drive":[17],"through":[19],"the":[20,24,33,41,51,96,99,124,131,146,152,167,176],"G1":[21],"stage":[22],"cell":[25],"cycle,":[26],"at":[27],"least":[28],"in":[29,65,84,106,116,183,188,205],"part,":[30],"by":[31],"inactivating":[32],"tumor":[34],"suppressor,":[35],"retinoblastoma.":[36],"CDK4/6":[37,43,70,102,127,150,162,179,203],"are":[38,78,93,112,141,193],"targetable":[39],"selective":[42],"inhibitor,":[44],"palbociclib,":[45],"was":[46],"recently":[47],"FDA":[48],"approved":[49],"for":[50],"treatment":[52],"estrogen":[54],"receptor\u2013positive,":[55],"HER2-negative":[56],"advanced":[57],"breast":[58],"cancer.":[59],"In":[60],"cutaneous":[61,206],"melanoma,":[62],"driver":[63],"mutations":[64],"NRAS":[66],"BRAF":[68,87],"promote":[69],"activation,":[71],"suggesting":[72],"that":[73,92,133,157],"inhibitors":[74,88,91,103,111,128,180,187,204],"such":[75],"as":[76],"palbociclib":[77],"likely":[79,194],"to":[80,101,119,161,174,195],"provide":[81],"therapeutic":[82],"benefit":[83],"combination":[85,107,184],"with":[86,108,159,185],"and/or":[89],"MEK":[90,164,186],"FDA-approved.":[94],"However,":[95],"determinants":[97],"response":[100,160],"alone":[104,181],"other":[109],"targeted":[110],"poorly":[113],"defined.":[114],"Furthermore,":[115],"vivo":[117],"systems":[118],"quantitatively":[120],"temporally":[122],"measure":[123],"efficacy":[125],"determine":[130,175],"extent":[132],"CDK":[134],"activity":[135],"reactivated":[137],"during":[138],"acquired":[139],"resistance":[140],"lacking.":[142],"Here,":[143],"we":[144],"describe":[145],"heterogeneous":[147],"effects":[148,177],"inhibitors,":[151,165],"expression":[153],"antiapoptotic":[155],"proteins":[156],"associate":[158],"development":[168],"luciferase-based":[171],"reporter":[172],"system":[173],"melanoma":[189],"xenografts.":[190],"These":[191],"findings":[192],"inform":[196],"on-going":[197],"future":[199],"clinical":[200],"trials":[201],"utilizing":[202],"melanoma.":[207],"Cancer":[208],"Res;":[209],"76(18);":[210],"5455\u201366.":[211],"\u00a92016":[212],"AACR.":[213]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-03-13T00:00:00"}